4.6 Editorial Material

PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease

Journal

RESPIROLOGY
Volume 28, Issue 3, Pages 212-214

Publisher

WILEY
DOI: 10.1111/resp.14399

Keywords

interstitial lung disease; phosphodiesterase type 5 inhibitor; pulmonary fibrosis; pulmonary hypertension; sildenafil; tadalafil; treatment

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available